Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21071270 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cetuximab + Gemox in Biliary Tract Cancer
Conditions: Unresectable;   Locally Advanced;   Metastatic
Intervention: Drug: Cetuximab + Gemcitabine + Oxaliplatin

Study has passed its completion date and status has not been verified in more than two years.